Can neuroinflammation, insulin resistance, oxidative stress, and low physical activity impair amyloid clearance and promote tau pathology?

At age 77, these processes are clinically relevant because vascular-metabolic dysfunction, inflammation, and low activity often coexist. The proposed convergence is biologically credible, but it is not established as a single, proven causal pathway in humans.

Amyloid and tau pathways

• Amyloid clearance: Neuroinflammation and oxidative stress can disrupt blood–brain-barrier integrity, microglial amyloid handling, enzymatic degradation, and perivascular/glymphatic drainage. Insulin resistance may compete with amyloid-beta for insulin-degrading enzyme and impair LRP1-associated efflux. However, human evidence directly measuring clearance kinetics under this combined exposure pattern is limited; exercise trials have not demonstrated reduced cerebral amyloid burden or altered glymphatic clearance.
• Tau pathology: Inflammatory signaling has the strongest mechanistic support. Microglial activation and IL-1–linked activation of p38 MAPK and GSK-3β can increase neuronal tau phosphorylation. Tau pathology may in turn activate microglia, creating a potentially self-reinforcing inflammatory loop. This evidence more firmly supports early phosphorylation than mature tau aggregation or its clinical progression.

Synaptic resilience and physical activity

• Insulin resistance can impair neuronal glucose utilization and mitochondrial function, amplifying oxidative stress and inflammatory signaling—conditions compatible with reduced neuroplasticity and greater synaptic vulnerability.
• In cognitively unimpaired older adults, higher step counts were associated with slower amyloid-related tau accumulation and slower cognitive/functional decline; tau change statistically mediated the activity–cognition association. Yet in sedentary adults with amnestic mild cognitive impairment, 12 months of aerobic exercise did not outperform flexibility/balance training on cognition, imaging, function, or Alzheimer biomarkers.

Bottom line

• The claim is plausible with moderate confidence: inflammatory, oxidative, and metabolic pathways can plausibly converge on impaired amyloid handling, tau phosphorylation, and synaptic vulnerability. But additive effects of all four factors, effects on mature tau deposition, and direct human proof of a unified causal pathway remain unestablished.